Interaction of Imatinib Mesilate with Human P-Glycoprotein
Data up to Jan 2025
Total Citations Per Year
Abstract
References (35)
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 • 5,189 citations
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
1995 • 1,109 citations
MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine
1996 • 863 citations
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
1995 • 856 citations
Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance
2000 • 789 citations
The multidrug transporter, a double-edged sword.
1988 • 763 citations
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
1992 • 677 citations
Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study
1999 • 596 citations
Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification
2000 • 511 citations
Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.
1993 • 508 citations
Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.
1996 • 487 citations
Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl–positive cells
2000 • 291 citations
In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents
2001 • 274 citations
Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux
2002 • 269 citations
Mrp1 Multidrug Resistance‐Associated Protein and P‐Glycoprotein Expression in Rat Brain Microvessel Endothelial Cells
1998 • 265 citations
Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336
2002 • 255 citations
Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl–positive cells
2000 • 244 citations
Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1
2002 • 209 citations
Pgp and MRP Activities Using Calcein-AM Are Prognostic Factors in Adult Acute Myeloid Leukemia Patients
1998 • 208 citations
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Anticancer Agents
2000 • 191 citations
Interaction of Cytochrome P450 3A Inhibitors with P-Glycoprotein
2002 • 137 citations
Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers.
1999 • 124 citations
Chronic myelogenous leukemia
2001 • 90 citations
HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer
2002 • 82 citations
Mechanism of action of rituximab.
2001 • 79 citations
The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein.
2001 • 62 citations
Microfluorometric Evaluation of Calcein Acetoxymethyl Ester as a Probe for P-Glycoprotein-Mediated Resistance: Effects of Cyclosporin A and Its Nonimmunosuppressive Analogue SDZ PSC 833
1994 • 57 citations
Targeted therapies in the treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia
2002 • 47 citations
Tyrosine kinase inhibitors: A clinical perspective
2002 • 38 citations
Gleevec does not cross blood–brain barrier
2003 • 35 citations
Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.
1999 • 32 citations
Bromocriptine Reverses P‐Glycoprotein‐mediated Multidrug Resistance in Tumor Cells
2002 • 26 citations
Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines
2001 • 26 citations
Epidemiology of the acquired immunodeficiency syndrome (AIDS) in the United States.
1984 • 23 citations
Increase in the Level of P‐Glycoprotein mRNA Expression in Multidrug‐resistant K562 Cell Lines Treated with Sodium Butyrate Is Not Accompanied with Erythroid Differentiation
1990 • 11 citations
Cited By (0)
No citing papers found in database